{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:12:32Z","timestamp":1793650352904,"version":"4.5.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2504100"],"award-info":[{"award-number":["2022YFC2504100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82025010"],"award-info":[{"award-number":["82025010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2019-I2M-5-022"],"award-info":[{"award-number":["2019-I2M-5-022"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.eclinm.2024.102467","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T17:53:25Z","timestamp":1707242005000},"page":"102467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised, double-blind, phase 2 trial"],"prefix":"10.1016","volume":"69","author":[{"given":"Yuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xicheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuida","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengshuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2024.102467_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/alr.23090","article-title":"International consensus statement on allergy and rhinology: allergic rhinitis - 2023","volume":"13","author":"Wise","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.eclinm.2024.102467_bib2","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/all.12874","article-title":"An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011","volume":"71","author":"Wang","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.eclinm.2024.102467_bib3","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/all.12470","article-title":"Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review","volume":"69","author":"Zuberbier","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.eclinm.2024.102467_bib4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/all.13099","article-title":"Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study","volume":"72","author":"Colas","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.eclinm.2024.102467_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12148","article-title":"Direct and indirect costs of allergic and non-allergic rhinitis to adults in Beijing, China","volume":"12","author":"Li","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.eclinm.2024.102467_bib6","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mai.2001.115569","article-title":"Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis","volume":"108","author":"Skoner","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.eclinm.2024.102467_bib7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/cea.12638","article-title":"Pollinosis and all-cause mortality among middle-aged and elderly Japanese: a population-based cohort study","volume":"46","author":"Konishi","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.eclinm.2024.102467_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13223-015-0093-x","article-title":"Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis","volume":"11","author":"Konig","year":"2015","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.eclinm.2024.102467_bib9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1398-9995.2005.00602.x","article-title":"Seasonal and perennial allergic rhinitis: is this classification adherent to real life?","volume":"60","author":"Ciprandi","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.eclinm.2024.102467_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/all.14561","article-title":"Clinical characteristics of allergic rhinitis patients in 13 metropolitan cities of China","volume":"76","author":"Zheng","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.eclinm.2024.102467_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.115903","article-title":"Effects of pollen concentration on allergic rhinitis in children: a retrospective study from Beijing, a Chinese megacity","volume":"229","author":"Zhao","year":"2023","journal-title":"Environ Res"},{"issue":"Suppl 86","key":"10.1016\/j.eclinm.2024.102467_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the world health organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.eclinm.2024.102467_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2222.1998.00237.x","article-title":"Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?","volume":"28","author":"White","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.eclinm.2024.102467_bib14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1517\/14712598.2013.795943","article-title":"Omalizumab for treatment of allergic rhinitis","volume":"13","author":"Vashisht","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.eclinm.2024.102467_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12094","article-title":"Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis","volume":"12","author":"Zhang","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.eclinm.2024.102467_bib16","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1001\/jama.286.23.2956","article-title":"Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial","volume":"286","author":"Casale","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2024.102467_bib17","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1016\/j.jaip.2020.04.068","article-title":"Add-on omalizumab for inadequately controlled severe pollinosis despite standard-of-care: a randomized study","volume":"8","author":"Okubo","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.eclinm.2024.102467_bib18","first-page":"501","article-title":"Omalizumab for the treatment of allergic rhinitis: a systematic review and meta-analysis","volume":"59","author":"Tsabouri","year":"2021","journal-title":"Rhinology"},{"key":"10.1016\/j.eclinm.2024.102467_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd4624","article-title":"Targeting key proximal drivers of type 2 inflammation in disease","volume":"15","author":"Gandhi","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.eclinm.2024.102467_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2024.102467_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaci.2017.11.051","article-title":"Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma","volume":"142","author":"Weinstein","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.eclinm.2024.102467_bib22","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2147\/JAA.S318892","article-title":"Short-Term subcutaneous allergy immunotherapy and dupilumab are well tolerated in allergic rhinitis: a randomized trial","volume":"14","author":"Corren","year":"2021","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.eclinm.2024.102467_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102076","article-title":"Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial","volume":"61","author":"Zhang","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102467_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/CM9.0000000000002747","article-title":"Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 2b trial","volume":"137","author":"Zhao","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.eclinm.2024.102467_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100545","article-title":"Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapy","volume":"14","author":"Justicia","year":"2021","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.eclinm.2024.102467_bib26","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.jaip.2020.11.046","article-title":"Serum periostin as a biomarker for predicting clinical response to house dust mite sublingual immunotherapy in allergic rhinitis","volume":"9","author":"Hoshino","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.eclinm.2024.102467_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0140-6736(22)02037-2","article-title":"An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study","volume":"401","author":"Guttman-Yassky","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.102467_bib28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bjd\/ljad240","article-title":"Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial","volume":"189","author":"Weidinger","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.eclinm.2024.102467_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(21)00338-1","article-title":"Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials","volume":"7","author":"Rubin","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.eclinm.2024.102467_bib30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/bjd.19460","article-title":"Dupilumab provides favourable long-term safety and efficacy in children aged >\/= 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study","volume":"184","author":"Cork","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.eclinm.2024.102467_bib31","series-title":"Dupixent (dupilumab) injection [package insert]","year":"2022"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:39:46Z","timestamp":1781642386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":31,"alternative-id":["S2589537024000464"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102467","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised, double-blind, phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102467"}}